We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
(+9.5%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$516M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$253M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$210M |
| 4 |
Broadcom
AVGO
|
+$161M |
| 5 |
Uber
UBER
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$340M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$328M |
| 3 |
VMW
VMware, Inc
VMW
|
+$255M |
| 4 |
Chevron
CVX
|
+$187M |
| 5 |
lululemon athletica
LULU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Healthcare | 16.39% |
| 3 | Financials | 11.55% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Karyopharm Therapeutics
KPTI
$44.2M
| $1.44M | ﹤0.01% |
+110,887
| New | +$1.49M |
|
752
American Homes 4 Rent
AMH
$12.4B
| $1.43M | ﹤0.01% |
+39,719
| New | +$1.39M |
|
753
BP
BP
$109B
| $1.42M | ﹤0.01% |
40,000
+10,000
| +33% | +$366K |
|
754
BioXcel Therapeutics
BTAI
$25.6M
| $1.37M | ﹤0.01% |
29,086
+16,586
| +133% | +$922K |
|
755
Immunocore
IMCR
$1.75B
| $1.37M | ﹤0.01% |
+20,000
| New | +$1.04M |
|
|
SLRN
756
DELISTED
ACELYRIN
SLRN
| $1.34M | ﹤0.01% |
180,000
+80,000
| +80% | +$683K |
|
757
Caribou Biosciences
CRBU
$163M
| $1.17M | ﹤0.01% |
203,933
-50,000
| -20% | -$247K |
|
758
Excelerate Energy
EE
$1.21B
| $1.16M | ﹤0.01% |
75,000
-237,500
| -76% | -$3.82M |
|
759
Moog Inc Class A
MOG.A
$13B
| $1.09M | ﹤0.01% |
7,553
| – | – |
|
|
MTEM
760
DELISTED
Molecular Templates, Inc.
MTEM
| $1.09M | ﹤0.01% |
292,764
| – | – |
|
761
Parker-Hannifin
PH
$135B
| $1.06M | ﹤0.01% |
+2,296
| New | +$956K |
|
762
U-Haul Holding Co Series N
UHAL.B
$12.8B
| $1.06M | ﹤0.01% |
+15,000
| New | +$816K |
|
|
CVAC
763
DELISTED
CureVac
CVAC
| $1.05M | ﹤0.01% |
+248,428
| New | +$1.35M |
|
|
PLGO
764
Pelagos Insurance Capital
PLGO
$2.18B
| $950K | ﹤0.01% |
75,000
+64,400
| +608% | +$865K |
|
765
OPAL Fuels
OPAL
$72.6M
| $883K | ﹤0.01% |
160,000
-66,667
| -29% | -$412K |
|
766
BJs Wholesale Club
BJ
$12.4B
| $880K | ﹤0.01% |
13,200
-236,800
| -95% | -$16M |
|
767
ProPetro Holding
PUMP
$1.34B
| $838K | ﹤0.01% |
100,000
| – | – |
|
|
SPR
768
DELISTED
Spirit AeroSystems
SPR
| $804K | ﹤0.01% |
25,311
-852,797
| -97% | -$20.9M |
|
769
Energy Recovery
ERII
$450M
| $801K | ﹤0.01% |
42,491
+28,084
| +195% | +$521K |
|
770
Taysha Gene Therapies
TSHA
$1.82B
| $743K | ﹤0.01% |
420,000
-1,080,000
| -72% | -$2.15M |
|
771
Immuneering
IMRX
$289M
| $735K | ﹤0.01% |
100,000
-95,000
| -49% | -$633K |
|
|
ALLK
772
DELISTED
Allakos
ALLK
| $683K | ﹤0.01% |
+250,100
| New | +$563K |
|
|
FARM
773
DELISTED
Farmer Brothers
FARM
| $677K | ﹤0.01% |
221,229
-30,000
| -12% | -$82.1K |
|
774
Lifezone Metals Ltd Warrants
LZM.WS
$27.4M
| $673K | ﹤0.01% |
1,258,463
| – | – |
|
|
CPRX
775
DELISTED
Catalyst Pharmaceutical
CPRX
| $672K | ﹤0.01% |
+40,000
| New | +$547K |
|
Similar funds
Adage Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
- Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
- Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
- Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
- Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
- Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
- Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.
Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.